Mersana Therapeutics, Inc. (DELISTED) (MRSN:DL)
29.08
0.00 (0.00%)
USD |
NASDAQ |
Jan 15, 16:00
Mersana Therapeutics EPS Diluted (Quarterly): -1.511 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Cidara Therapeutics, Inc. | -3.096 |
| Day One Biopharmaceuticals, Inc. | -0.1908 |
| Semler Scientific, Inc. | 1.075 |
| Cue Biopharma, Inc. | -0.0738 |
| Scholar Rock Holding Corp. | -0.8988 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -7.545M |
| Revenue (Quarterly) | 11.01M |
| Total Expenses (Quarterly) | 18.55M |
| Enterprise Value | 90.40M |
| Gross Profit Margin (Quarterly) | 99.25% |
| Profit Margin (Quarterly) | -68.53% |
| Earnings Yield | -32.44% |
| Normalized Earnings Yield | -30.25 |